Fig. 4

Proportion of costs attributed to patients with ASCVD-risk equivalent and ASCVD, over total costs, stratified by age group, in 2021. ASCVD-risk equivalent: Very high CVD risk without prior ASCVD; ASCVD: Very high CVD risk with prior ASCVD